Allergan, Inc. Product Pipeline Analysis

Published by: Global Markets Direct

Published: May. 29, 2008 - 55 Pages

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Company Snapshot

2.1 Key Information

2.2 Company Overview

2.3 Financial Performance

3 Allergan, Inc. Pipeline Products

3.1 Allergan, Inc. Product Pipeline Analysis

3.1.1 Allergan, Inc. Pipeline Products By Equipment Type

3.1.2 Allergan, Inc. Pipeline Products By Development Stage

3.1.3 Allergan, Inc. Pipeline Products By Therapy Area

3.1.4 Allergan, Inc. Pipeline Products By Clinical Trials

3.1.5 Allergan, Inc. Pipeline Products By News Summary

3.2 Silicone Breast Implant -Cohesive Silicone Gel Matrix (Style 410)

3.2.1 Product Description

3.2.2 Product Status

3.3 VOLUMA

3.3.1 Product Description

3.3.2 Product Status

3.4 EASYBAND

3.4.1 Product Description

3.4.2 Product Status

3.4.3 Clinical Trials

3.5 BioEnterics Intragastric Balloon

3.5.1 Product Description

3.5.2 Product Status

3.5.3 Product Milestone

3.5.4 Product Patent Details

3.5.5 Product Patent Details

3.6 LAP-BAND

3.6.1 Product Description

3.6.2 Product Status

3.6.3 Clinical Trials

3.6.4 Product Patent Details

3.6.5 Product Patent Details

4 Business Description

4.1 Business Overview

4.2 Major Products and Services

4.2.1 Overview

5 History

6 Competitors

7 Key Employees

8 Key Employee Biographies

9 Company Statement

10 Locations And Subsidiaries

10.1 Head Office

10.2 Other Locations & Subsidiaries

11 Financial Deals Landscape

11.1 Acquisition

11.1.1 Allergan Acquires Esprit Pharma

11.1.2 Allergan Acquires Endoart

11.2 Debt Offerings

11.2.1 Allergan Completes Private Placement Of Convertible Senior Notes

11.2.2 Allergan Completes Private Placement Of Senior Notes

11.3 Partnership

11.3.1 Covidien Signs An Agreement With Allergan

12 Recent Developments

12.1 Financial Announcements

12.1.1 May 07, 2008: Allergan Declares Quarterly Dividend

12.1.2 May 07, 2008: Allergan Declares Q1 2008 Results

12.1.3 Jan 30, 2008: Allergan Declares Quarterly Dividend

12.1.4 Jan 30, 2008: Allergan Declares Q4 2007 Results

12.1.5 Nov 06, 2007: Allergan Declares Quarterly Dividend

12.1.6 Nov 06, 2007: Allergan Declares Q3 2007 Results

12.1.7 Aug 01, 2007: Allergan Reports Q2 2007 Results

12.1.8 Aug 01, 2007: Allergan Declares Quarterly Dividend

12.1.9 May 02, 2007: Allergan Reports Q1 2007 Results

12.1.10 May 02, 2007: Allergan Declares Quarterly Dividend

12.1.11 Jan 31, 2007: Allergan Reports Q4 2006 Results

12.1.12 Jan 31, 2007: Allergan Declares Quarterly Dividend

12.2 Other Significant Developments

12.2.1 Dec 06, 2007: Allergan Appoints Board Member

13 Appendix

13.1 Methodology

13.1.1 Coverage

13.1.2 Secondary Research

13.1.3 Primary Research

13.1.4 Expert Panel Validation

13.2 Contact Us

13.3 About Global Markets Direct

13.4 Disclaimer

1.1 List of Tables

Table 1: Allergan, Inc.,Key Facts

Table 2: Allergan, Inc. Pipeline Products by Equipment Type

Table 3: Allergan, Inc. Pipeline Products By Development Stage

Table 4: Allergan, Inc. Pipeline Products By Therapy Area

Table 5: Allergan, Inc. Pipeline Products By Clinical Trials

Table 6: Allergan, Inc. Pipeline Products By News Summaries

Table 8: Allergan, Inc., Key Employees,

Table 9: Allergan, Inc., Subsidiaries

1.2 List of Figures

Figure 1: Global Markets Direct Methodology

Abstract

• Details of development stage by sector and equipment type.
• Pipeline products grouped by therapy area, development stage and trial phase.
• Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
• Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
• Product updates covering estimated approval dates and estimated launch dates.
• Descriptions of novel technologies relating to pipeline products of the company.
• Patents and patent applications covered for the product.
• News updates on key events relating to the product and its development.

• A single source to fulfill competitor information relating to products in development.
• Identify pipeline products that are potential competitor to your product lines.
• Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
• Access clinical trial information to map trial results and plan targeted marketing activities.
• Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
• Identification of potential investment opportunities.
• Build up knowledge base for potential distribution and marketing partners.
• Helps avoid patent infringement.
• Timelines from concept to market lets you keep track of market potential build for a new product.
• Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.